In the OIS Podcast, ExSight Ventures discuss why they invested into Re-Vana. Here is the segment where they discuss Re-Vana Therapeutics:
Listen to the Full Podcast Here
(Discussion of Re-Vana commences at 43 minutes.)
https://ois.net/venturing-into-ophthalmology-with-exsight-podcast/